scispace - formally typeset
Open AccessJournal Article

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, +80 more
- 01 Oct 2003 - 
- Vol. 42
Reads0
Chats0
About
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.

read more

Citations
More filters
Journal ArticleDOI

Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease

TL;DR: Evidence that two early complications of chronic kidney disease--vitamin D deficiency and secondary hyperparathyroidism--contribute to bone and cardiovascular disease is discussed.
Journal ArticleDOI

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study

TL;DR: In addition to improving hyperparathyroidism, vitamin D supplementation with daily cholecalciferol had a beneficial effect in decreasing albuminuria with potential effects on delaying the progression of CKD.
Journal ArticleDOI

Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study.

TL;DR: The prevalence of 25(OH) vitamin D (calcidiol) deficiency/insufficiency at the time of renal transplant is very high and the clinical effects of this deficiency/ Insufficiency deserve further study.
Journal ArticleDOI

Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: data from the UK renal registry.

TL;DR: Many patients in stage 4T–5T CKD‐related complications that fall below targets established for nontransplant CKD patients are at increased risk of graft loss and more attention needs to be paid to managing these complications and preparing patients for a return to dialysis and/or retransplantation.
Journal ArticleDOI

An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis

TL;DR: Denosumab is effective in restoring bone mass and reducing bone pain in patients on dialysis with secondary hyperparathyroidism and allows for a more aggressive use of calcitriol to control hyperparathiroidism.
References
Related Papers (5)